BioGenes GmbH

Just one week to go until BIO-Europe 2024! We are happy to share that our 2 delegates Dr Yvonne Haberkorn (Head of Business Development and Marketing) and Janine Jung (Project Manager Immunoassay Development & Analytics) will be there - if not done yet, you can organize a meeting with them to discuss how BioGenes can assist you in your projects. Looking forward to network and foster partnerships in Stockholm! #bioeurope #networking

Would you like to learn more about the critical role of Host Cell Proteins (HCPs) in viral vector manufacturing for gene therapy products? We’re excited to share our latest white paper: “Analytics of Host Cell Proteins in Viral Vector Manufacturing for Gene Therapy Products.” This white paper dives deep into key challenges and innovative solutions for ensuring product purity, including: 🔍 How HEK293 cell lines are commonly used in viral vector-based gene therapy 🔬 The significance of HCP analysis to control impurities, maintain product safety, and ensure batch consistency ⚙️ Info about our innovative HEK293|360-HCP ELISA kits designed for precise HCP monitoring This resource is essential for anyone involved in gene therapy manufacturing, from R&D to production, offering advanced tools for HCP profiling and optimization. 📥 Download the full white paper here: https://lnkd.in/df597Hpz #GeneTherapy #ViralVectorManufacturing #HCPAnalytics #Bioprocessing

Next stop: BIO-Europe in Stockholm 🇸🇪 We are really happy to report that our participation in the Festival of Biologics in Basel this week was a tremendous success. We would like to express our gratitude to all who visited our booth and exchanged with our delegates - the connections made at the event will undoubtedly fuel new opportunities for growth and collaboration in the months to come. Next step for us is now BIO-Europe, taking place in Stockholm on November 4th-6th! BIO-Europe is one of the premier partnering events in the biotechnology industry, bringing together leading companies, researchers, and investors from around the world. We are excited to present our latest developments there and engage with leading experts to explore potential collaborations that will shape the future of the industry.

The Festival of Biologics 2024 has officially started! 🎉 Our Biogenes team is already on-site, excited to meet you at our stand 818. Whether you're looking for new partnering opportunities or simply want to connect, we're here to discuss how our innovative solutions can support your projects. Come by and say hello—we look forward to insightful conversations and building new connections! #fob #biotech #networking

The countdown is on! ✨ Next stop: Festival of Biologics 2024 in Basel 🇨🇭. We’re thrilled to be part of this leading biologics event where science meets innovation. Will you be there too? 📍 Come find us at Booth 818 and meet our deleguates: Jenny Pressl (Head of Antibody Development) Dethlef Schmechel (Expert Monoclonal Antibody Development) Dailén García Martínez (Project Manager Antibody Development) Steffi Struwe (Project Manager Immunoassay Development & Analytics) Come arrange a meeting with them! #fob #networking

Our Corporate Video is here! We’re thrilled to share the launch of our brand-new Corporate Video today 🎥 This video offers an exciting insight into our vision, our values and our strengths. It is the result of great collaboration - a big thank you to everyone involved in its creation! Take a look and feel free to share it with your network: https://lnkd.in/dRB2cJwj We hope you enjoy the video as much as we do! #corporatevideo #teamwork #companyculture #biotech

We’re thrilled to announce that Biogenes will be attending the Festival of Biologics again, this year in Basel from October 15-17! Join us for a deep dive into the latest trends and innovations in biologics, where our team will showcase how Biogenes is advancing the future of precision diagnostics and biotechnologies. Stay tuned for more info next week 🔍 #FestivalofBiologics #PrecisionDiagnostics #Biotechnology #Innovation

At Biogenes, the success of our clients is the true measure of our commitment to quality and innovation. We’re thrilled to share another detailed testimonial that showcases how our solutions are making a real difference. “Outsourcing antibody and ELISA development to BioGenes has been one of the best investments of my career. Custom reagents they developed allowed us to make fundamental discoveries and be highly innovative and competitive in our scientific endeavours. BioGenes staff are incredibly knowledgeable, highly efficient, and brilliant at developing bespoke solutions for each project. Open-door, open-mind policy, allowing us to establish an excellent rapport over the years. Staff promptly respond and address questions and concerns. I never felt I was misunderstood, misled or money gouged. BioGenes always come through with the goods in a timely and feasible manner. I highly recommend BioGenes for any researcher with antibody and ELISA needs. Money well spent and highly trusted company.’’   Yotis Senis, PhD, Inserm Research Director, ERC Advanced Grant Laureate 2024.

#Hiring – Wir suchen eine:n neue:n Technischer Mitarbeiter im Bereich Immunoassayproduktion (m/w/d) in Berlin. Bewerben Sie sich noch heute oder teilen Sie diese Stellenanzeige mit Ihrem Netzwerk.

#Hiring – Wir suchen eine:n neue:n technischer Mitarbeiter im Bereich Immunoassayproduktion (m/w/d) in Berlin. Bewerben Sie sich noch heute oder teilen Sie diese Stellenanzeige mit Ihrem Netzwerk!